MRK vs. PFE
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or PFE.
Correlation
The correlation between MRK and PFE is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MRK vs. PFE - Performance Comparison
Key characteristics
MRK:
-1.34
PFE:
-0.28
MRK:
-1.78
PFE:
-0.25
MRK:
0.76
PFE:
0.97
MRK:
-0.87
PFE:
-0.12
MRK:
-1.65
PFE:
-0.59
MRK:
19.22%
PFE:
10.73%
MRK:
23.69%
PFE:
22.83%
MRK:
-68.62%
PFE:
-54.82%
MRK:
-33.50%
PFE:
-53.83%
Fundamentals
MRK:
$218.22B
PFE:
$137.76B
MRK:
$6.74
PFE:
$1.41
MRK:
12.82
PFE:
17.23
MRK:
0.79
PFE:
0.58
MRK:
$48.39B
PFE:
$48.75B
MRK:
$39.64B
PFE:
$31.22B
MRK:
$19.98B
PFE:
$12.18B
Returns By Period
In the year-to-date period, MRK achieves a -12.41% return, which is significantly lower than PFE's -6.93% return. Over the past 10 years, MRK has outperformed PFE with an annualized return of 7.97%, while PFE has yielded a comparatively lower 1.07% annualized return.
MRK
-12.41%
-5.86%
-20.28%
-31.52%
6.74%
7.97%
PFE
-6.93%
-5.67%
-11.52%
-5.17%
-1.02%
1.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. PFE — Risk-Adjusted Performance Rank
MRK
PFE
MRK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. PFE - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.66%, less than PFE's 6.96% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.66% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
PFE Pfizer Inc. | 6.96% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Drawdowns
MRK vs. PFE - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for MRK and PFE. For additional features, visit the drawdowns tool.
Volatility
MRK vs. PFE - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 7.09% compared to Pfizer Inc. (PFE) at 6.12%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities